Schneider Joel Solomon Zev
Known title: Chief Operating OfficerCIK: 0001727649
Associated companies
Transaction History
| SLDB | ▼ Sell | Open Market | 15,232 | $17K | 3/14/2022 | View on chart |
| SLDB | ▼ Sell | Open Market | 15,272 | $17K | 3/14/2022 | View on chart |
| SLDB | ▼ Sell | Open Market | 15,232 | $17K | 3/14/2022 | View on chart |
| SLDB | ▼ Sell | Open Market | 15,272 | $17K | 3/14/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SLDB Featured in After-Market Movers List
Solid Biosciences was included in a Benzinga list of healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with an RSI of 20.5 indicating oversold conditions. Analysts maintain an average price target of $18.62, which is significantly higher than the current trading range.
SLDB Featured in After-Market Movers List. Solid Biosciences was included in a Benzinga list of healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with an RSI of 20.5 indicating oversold conditions. Analysts maintain an average price target of $18.62, which is significantly higher than the current trading range.